Please do not leave this page until complete. This can take a few moments.
A Braintree home and hardware supply company has purchased the former Empire Beauty School location on Route 9 in Framingham for nearly $1.53 million.
Hindsight is 20/20, and it is hard to understand the full depth and consequences for the future in any given moment; but the healthcare industry, regulators and pharmaceutical companies should have reversed course well before the opioid crisis cost
Worcester Polytechnic Institute is working with a Holliston-based manufacturer of prosthetic devices to develop wireless sensors to improve the performance of upper-limb prosthetics.
The stock of Hopkinton drugmaker Spring Bank Pharmaceuticals was up nearly 10% Monday on the news its new drug was accepted into the U.S. Food and Drug Administration's drug program to begin clinical trials.
Harvard Bioscience opened the stock market on Friday trending up more than 20% after its second-quarter earnings reflected an improved financial condition as the company focuses on improving its underlying performance.
Holliston life science equipment manufacturer Harvard Bioscience has replaced President and CEO Jeffrey Duchemin with four-year director James Green.
Worcester aesthetic and dermatology firm Or-Genix Therapeutics has created a new position and hired 20-year corporate development executive Cristina Griffin.
Greater Good Imperial Brewing Co. in Worcester has quickly become one of Central Massachusetts’ most popular brands of craft beer, but founder Paul Wengender’s background might surprise some.
Hopkinton startup drugmaker Spring Bank Pharmaceuticals opened Monday trading up more than 5% after the company said it submitted an application to the U.S. Food and Drug Administration for a new cancer treatment.
Marlborough medical device company Hologic has made an $85-million offer to acquire France breast imaging firm SuperSonic Image.
Illinois drugmaker AbbVie, with a bioresearch center in Worcester employing 900, is acquiring the Irish maker of Botox in a cash and stock deal worth $63 billion.
Inside dozens of closet-sized laboratories in three different Worcester buildings is a goldmine of biotechnology brainpower and promising research just waiting for the right opportunity to explode onto the marketplace.
Gov. Baker is seeking the help of technology industry executives in passing education and housing legislation that he described as critical to developing and retaining a highly qualified workforce.
Thanks to several decades of hard work and planning and the growth of life science business parks in Worcester, the biotech cluster in Central Massachusetts is becoming known on the world stage.
The biomanufacturing park being built at the site of the former Worcester State Hospital will now be known as The Reactory, according to landowner Worcester Business Development Corp.